How Browne was paid
$1.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Sean E. BrownePresident and Chief Executive Officer | $624,000 | $100,000 | $588,812 | — | $38,864 | $1,351,676 |
| Mark A. SchallenbergerChief Operating Officer | $447,680 | $100,000 | $435,720 | $113,131 | $14,000 | $1,110,531 |
| Scott C. NeilsChief Financial Officer | $416,000 | $100,000 | $392,541 | — | $30,828 | $939,369 |
What changed and why
- $1.4M$1,351,676 CEO total compensation in 2025 versus $2,461,736 in 2024.
- $100K$100,000 discretionary bonus awarded to each named executive for 2025 performance and retention.
- $589K$588,812 CEO stock awards in 2025 versus $1,807,132 in 2024.
- $113K$113,131 non-equity incentive compensation was earned by Schallenberger, the only named executive receiving such a payout.
- 50%50% DSU or RSU awards and 50% PSU awards comprised the 2025 executive equity program.
Other Xtant Medical Holdings proxy statements
- 2025 proxy statement
Sean E. Browne paid $2.5M (+44% on the year).
Filed Sep 15, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.